| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $79,076 | +2,037 | +28% | $38.82 | 9,256 | 15 Mar 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $407,502 | -2,037 | -22% | $200.05 | 7,219 | 15 Mar 2023 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Sale | $64,016 | -320 | -4.4% | $200.05 | 6,899 | 15 Mar 2023 | Direct | F2, F3 |
| transaction | SGEN | Common Stock | Sale | $249,262 | -1,246 | -5.1% | $200.05 | 23,060 | 15 Mar 2023 | by Trust | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2,037 | -67% | $0.000000 | 995 | 15 Mar 2023 | Common Stock | 2,037 | $38.82 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $200.00 to $200.20. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Options were fully vested on 5/19/17. |